Skip to main content

A new class of innovative TCR therapies to cure cancer


About us

Axis is a leading immunotherapy company focused on developing T cell therapies to address major unmet medical needs of cancer patients around the world


Our TCR-T technology is at the forefront of cell immunotherapies and our mission is to create more effective and safe T cell therapies that target a broader range of cancers